We give you a written timeline estimate for your case before you commit.Get my quote
Is Fayuvi available in Qatar? How families get Fayuvi (rebisufligene etisparvovec-hopf)
A plain answer for families in Qatar, checked against FDA, manufacturer and regulator sources.
Reviewed by the Reserve Meds clinical operations team on 13 October 2026.
Is Fayuvi available in Qatar?
Fayuvi (rebisufligene etisparvovec-hopf) is an FDA-approved one-time AAV9 gene therapy for Sanfilippo syndrome type A (MPS IIIA) in children. As of 13 October 2026, we found no public record that Fayuvi is registered by MoPH in Qatar. Fayuvi is given only at specialized treatment centers, so for most families in Qatar the realistic route is treatment at a qualified center abroad, after a referral from the treating specialist. If a hospital in Qatar wants to give it locally, the manufacturer must agree to supply that hospital and the Ministry of Public Health (MoPH) must approve the import. Plan in months, not weeks (our planning estimate, not a promise). Reserve Meds helps organize the referral and logistics. We do not prescribe.
- Registration in Qatar: not found in public sources as of 13 October 2026. Your hospital confirms before filing.
- Legal route: Treatment at a qualified center abroad, or a hospital import request if the manufacturer agrees.
- Who applies: your treating specialist refers the patient to a qualified center; a hospital in Qatar applies to MoPH only if the manufacturer agrees to supply it.
- Timeline: several months (not a promise).
- Medicine price: quote on request. Every case gets a written custom quote before you commit.
What Fayuvi is
Fayuvi (rebisufligene etisparvovec-hopf) is made by Ultragenyx Pharmaceutical. The US FDA approved it on 17 September 2026 for the neurologic manifestations of mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo syndrome type A) in pediatric patients with preserved neurodevelopmental function. It is given as a single intravenous (IV) infusion, given in a specialized healthcare setting.
It is the first FDA-approved treatment for Sanfilippo syndrome type A. Ultragenyx said the FDA granted standard (full) approval. The treating team will explain the monitoring needed before and after a gene therapy infusion.
At approval, Fayuvi was approved only in the United States. Ultragenyx announced in October 2026 that it had submitted a marketing application to the European Medicines Agency.
The legal route in Qatar
Fayuvi is a one-time infusion given in a specialized healthcare setting. Children must still have preserved neurodevelopmental function, so the treating team will assess the child first. Timing matters for this disease.
For a family in Qatar, that leaves two realistic routes. First, treatment at a qualified center abroad, after your specialist refers you and the center accepts the patient. Second, a hospital in Qatar asks the manufacturer, Ultragenyx Pharmaceutical, whether it will supply that hospital. If the manufacturer agrees, the hospital still needs import approval from the Ministry of Public Health (MoPH). We cannot promise that a manufacturer will agree.
How a hospital import request works in Qatar, if it is ever needed:
In Qatar, the Ministry of Public Health (MoPH), through its Department of Pharmacy and Drug Control, supervises the registration and importation of medicines.
For a medicine that is not registered in Qatar, the treating hospital asks MoPH for approval to import it for the patient. Your hospital pharmacy prepares the request and confirms the current MoPH procedure.
Qatar's hospitals already give some specialty therapies. For example, Sidra Medicine reported in April 2026 that it had treated its tenth patient with the Duchenne gene therapy Elevidys, and that the treatment is free for Qatari citizens.
Who does what
- Your treating specialist decides whether Fayuvi is right for the patient and writes the letter and prescription.
- The hospital refers the patient, or files a local import request if that becomes possible.
- The Ministry of Public Health (MoPH) decides whether to approve an import of an unregistered medicine.
- Ultragenyx Pharmaceutical makes Fayuvi and decides where it can be supplied.
- Reserve Meds can help organize records and logistics, and keeps your family updated. We do not give medical advice.
Documents you will usually need
- A referral letter from the treating specialist: diagnosis, test results and why this treatment is being considered
- Genetic or laboratory reports that confirm the diagnosis, translated into English where needed
- Recent clinic notes, imaging and a list of past treatments
- Passport and travel documents, if treatment happens abroad
- A funding plan: personal funds, insurer approval, or a government treatment-abroad decision
Timeline, step by step
- Referral. Your specialist prepares a referral letter and the medical records.
- Center review. A qualified treatment center reviews the records and decides whether the patient is eligible.
- Funding and travel. The family confirms funding and plans travel and accommodation.
- Preparation. The center runs tests and, for some products, collects cells or tissue to make the treatment.
- Treatment and follow-up. The patient is treated and then followed up by the center and the home specialist.
The overall time is our planning estimate, not a promise. The regulator and the manufacturer set their own timelines.
What Fayuvi costs
Medicine price: quote on request. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. We do not prescribe, and we do not decide what the regulator approves.
Ask about Fayuvi in Qatar
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is Fayuvi approved in Qatar?
As of 13 October 2026, we found no public record that Fayuvi is registered by MoPH in Qatar. At approval, Fayuvi was approved only in the United States. Ultragenyx announced in October 2026 that it had submitted a marketing application to the European Medicines Agency. Ask your hospital pharmacy to confirm the current status with MoPH's Department of Pharmacy and Drug Control before anything is filed.
Who applies for permission to use Fayuvi in Qatar?
For treatment abroad, your specialist refers the patient to a qualified center. For a local hospital import, the hospital applies to the Ministry of Public Health (MoPH), and the manufacturer must agree to supply.
How long does it take to get Fayuvi in Qatar?
Plan in months, not weeks. The center must review the records, accept the patient and prepare the treatment. This is our planning estimate, not a promise.
How much does Fayuvi cost?
Medicine price: quote on request. Your total cost, including shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Can Fayuvi be given in Qatar instead of abroad?
Only if the manufacturer agrees to supply a hospital in Qatar and MoPH approves the import. We will tell you honestly if that is not possible today.
Sources
Checked on 13 October 2026. Regulator rules change. Your hospital pharmacy confirms the current procedure before filing.
- FDA: FAYUVI (rebisufligene etisparvovec-hopf) product page, approved 17 Sep 2026
- Ultragenyx: approval of FAYUVI gene therapy, 17 Sep 2026 (press release via Finviz)
- WebMD: FDA approves Fayuvi (single IV infusion in a specialized healthcare setting)
- Qatar Ministry of Public Health: services for companies (pharmacy and drug control)
- Qatar MoPH medication importation note (importation is supervised by MoPH)
- Medicine price: quote on request. You get a written quote for your case before you commit.